- Home
- RLAY vs MIST Comparison
RLAY vs MIST Comparison
Compare RLAY & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLAY
- MIST
- Stock Information
- Founded
- RLAY 2015
- MIST 2003
- Country
- RLAY United States
- MIST Canada
- Employees
- RLAY N/A
- MIST N/A
- Industry
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- MIST Biotechnology: Pharmaceutical Preparations
- Sector
- RLAY Health Care
- MIST Health Care
- Exchange
- RLAY Nasdaq
- MIST Nasdaq
- Market Cap
- RLAY N/A
- MIST 53.9M
- IPO Year
- RLAY 2020
- MIST N/A
- Fundamental
- Price
- RLAY $2.97
- MIST $1.12
- Analyst Decision
- RLAY Strong Buy
- MIST Strong Buy
- Analyst Count
- RLAY 11
- MIST 2
- Target Price
- RLAY $18.40
- MIST $9.50
- AVG Volume (30 Days)
- RLAY 2.6M
- MIST 1.6M
- Earning Date
- RLAY 05-05-2025
- MIST 05-20-2025
- Dividend Yield
- RLAY N/A
- MIST N/A
- EPS Growth
- RLAY N/A
- MIST N/A
- EPS
- RLAY N/A
- MIST N/A
- Revenue
- RLAY $7,679,000.00
- MIST N/A
- Revenue This Year
- RLAY N/A
- MIST N/A
- Revenue Next Year
- RLAY $440.45
- MIST N/A
- P/E Ratio
- RLAY N/A
- MIST N/A
- Revenue Growth
- RLAY N/A
- MIST N/A
- 52 Week Low
- RLAY $1.78
- MIST $0.63
- 52 Week High
- RLAY $10.72
- MIST $2.75
- Technical
- Relative Strength Index (RSI)
- RLAY 52.88
- MIST 46.48
- Support Level
- RLAY $2.71
- MIST $1.28
- Resistance Level
- RLAY $3.48
- MIST $1.32
- Average True Range (ATR)
- RLAY 0.27
- MIST 0.12
- MACD
- RLAY 0.01
- MIST 0.03
- Stochastic Oscillator
- RLAY 51.61
- MIST 38.80
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).